{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:47:01Z","timestamp":1780400821504,"version":"3.54.1"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,16]]},"abstract":"<jats:p>This study seeks to understand the causal association between serum metabolites and different lung cancer types, an area yet to be extensively studied. We Used a two-sample Mendelian randomization (TSMR) approach, utilizing 486 blood metabolites as exposures and 3 distinct lung cancer types genome-wide association studies datasets as outcomes. We employed inverse variance weighting, MR-Egger, weighted median, simple mode, and weighted mode to estimate causal effects. We performed sensitivity analyses using Cochran Q test, MR-Egger intercept test, and MR-pleiotropy residual sum and outlier (MR-PRESSO). Linkage disequilibrium score (LDSC) analysis was conducted on the selected metabolites, and common confounding single nucleotide polymorphisms were eliminated using the human genotype-phenotype association Database. Metabolic pathway analysis was performed with MetaboAnalyst 5.0 software. Subsequently, a multivariate Mendelian randomization analysis was conducted to ascertain independent risk exposures. Our findings suggest independent risk factors for specific types of lung cancer: 7-methylxanthine and isoleucine for lung adenocarcinoma, cysteine and 1-arachidonoylglycerophosphocholine are identified as independent protective and risk factors for squamous lung cancer. Undecanoate (11:0) with Linoleate (18:2n6) showed a protective effect for small cell lung cancer. Additionally, 11 metabolic pathways were associated with lung cancer. This novel perspective offers a multidimensional understanding of lung cancer phenotypes, providing valuable guidance for identifying and screening of diverse lung cancer phenotypes.<\/jats:p>","DOI":"10.1097\/md.0000000000037085","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T19:02:07Z","timestamp":1708110127000},"page":"e37085","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The causal association between serum metabolites and lung cancer based on multivariate Mendelian randomization"],"prefix":"10.1097","volume":"103","author":[{"given":"Tao","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology Laboratory, The Affiliated Shaoyang Hospital, Hengyang Medical School, University of South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Scientific Research and Teaching, The Affiliated Shaoyang Hospital, Hengyang Medical School, University of South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Laboratory, The Affiliated Shaoyang Hospital, Hengyang Medical School, University of South China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1308-0795","authenticated-orcid":false,"given":"Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Scientific Research, The First Affiliated Hospital of Shaoyang University, Shaoyang, Hunan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"14300","DOI":"10.1038\/s41598-017-14513-7","article-title":"Incidence and mortality of lung cancer: global trends and association with socioeconomic status.","volume":"7","author":"Wong","year":"2017","journal-title":"Sci Rep"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"515606","DOI":"10.3389\/fonc.2020.515606","article-title":"Dual primary cancer patients with lung cancer as a second primary malignancy: a population-based study.","volume":"10","author":"Song","year":"2020","journal-title":"Front Oncol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3389\/fphys.2018.01710","article-title":"The evaluation of serum biomarkers for non-small cell lung cancer (NSCLC) diagnosis.","volume":"9","author":"Fang","year":"2018","journal-title":"Front Physiol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/cncr.32468","article-title":"Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC).","volume":"126","author":"Bodor","year":"2020","journal-title":"Cancer"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jtho.2016.03.024","article-title":"Absence of pathological proof of cancer associated with improved outcomes in early-stage lung cancer.","volume":"11","author":"Shaikh","year":"2016","journal-title":"J Thorac Oncol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1080\/19490976.2020.1737487","article-title":"Specific gut microbiome signature predicts the early-stage lung cancer.","volume":"11","author":"Zheng","year":"2020","journal-title":"Gut Microbes"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/19490976.2014.997612","article-title":"Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease.","volume":"6","author":"Minamoto","year":"2015","journal-title":"Gut Microbes"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.1038\/ncomms8208","article-title":"Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levels.","volume":"6","author":"Draisma","year":"2015","journal-title":"Nat Commun"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nmeth.4260","article-title":"Systems biology guided by XCMS Online metabolomics.","volume":"14","author":"Huan","year":"2017","journal-title":"Nat Methods"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1073\/pnas.1808950116","article-title":"Spatially resolved metabolomics to discover tumor-associated metabolic alterations.","volume":"116","author":"Sun","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1002\/ctm2.419","article-title":"A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma.","volume":"11","author":"Lv","year":"2021","journal-title":"Clin Transl Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1002\/cam4.6022","article-title":"Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: a Mendelian randomization study.","volume":"12","author":"Yun","year":"2023","journal-title":"Cancer Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13058-023-01609-4","article-title":"Association between human blood metabolome and the risk of breast cancer.","volume":"25","author":"Wang","year":"2023","journal-title":"Breast Cancer Res"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ygyno.2021.06.001","article-title":"Prospective analysis of circulating metabolites and endometrial cancer risk.","volume":"162","author":"Dossus","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1108086","DOI":"10.3389\/fgene.2023.1108086","article-title":"Assessing the causal relationships between human blood metabolites and the risk of NAFLD: a comprehensive Mendelian randomization study.","volume":"14","author":"Guo","year":"2023","journal-title":"Front Genet"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s42255-020-00316-0","article-title":"The hexosamine biosynthesis pathway is a targetable liability in KRAS\/LKB1 mutant lung cancer.","volume":"2","author":"Kim","year":"2020","journal-title":"Nat Metab"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"eabk2756","DOI":"10.1126\/scitranslmed.abk2756","article-title":"Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis.","volume":"14","author":"Wang","year":"2022","journal-title":"Sci Transl Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41467-019-09432-2","article-title":"Mendelian randomization analysis using mixture models for robust and efficient estimation of causal effects.","volume":"10","author":"Qi","year":"2019","journal-title":"Nat Commun"},{"key":"R19-20250504","first-page":"7","article-title":"Expressing results from a Mendelian randomization analysis: separating results from inferences.","volume":"6","author":"Burgess","year":"2021","journal-title":"JAMA Cardiol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.25293","article-title":"Mendelian randomization: progressing towards understanding causality.","volume":"84","author":"K\u00f6nig","year":"2018","journal-title":"Ann Neurol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1161\/CIRCULATIONAHA.120.046889","article-title":"Letter by gill regarding article, \u201cwhite blood cells and blood pressure: a mendelian randomization study.\u201d.","volume":"142","author":"Gill","year":"2020","journal-title":"Circulation"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ije\/dyv071","article-title":"Mendelian randomization studies: a review of the approaches used and the quality of reporting.","volume":"44","author":"Boef","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1681\/ASN.2020121760","article-title":"Mendelian randomization analysis as a tool to gain insights into causes of diseases: a primer.","volume":"32","author":"Tin","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in two-sample Mendelian randomization.","volume":"40","author":"Burgess","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ng.2982","article-title":"An atlas of genetic influences on human blood metabolites.","volume":"46","author":"Shin","year":"2014","journal-title":"Nat Genet"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"e1003005","DOI":"10.1371\/journal.pgen.1003005","article-title":"Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information.","volume":"8","author":"Krumsiek","year":"2012","journal-title":"PLoS Genet"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1093\/nar\/gkr988","article-title":"KEGG for integration and interpretation of large-scale molecular data sets.","volume":"40","author":"Kanehisa","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41576-023-00584-y","article-title":"The FinnGen study: disease insights from a \u2018bottlenecked\u2019 population.","volume":"24","author":"Minton","year":"2023","journal-title":"Nat Rev Genet"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/add.15142","article-title":"Bidirectional effects between loneliness, smoking and alcohol use: evidence from a Mendelian randomization study.","volume":"116","author":"Wootton","year":"2021","journal-title":"Addiction"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases.","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat Genet"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/schbul\/sbz138","article-title":"Assessing the causal effects of human serum metabolites on 5 major psychiatric disorders.","volume":"46","author":"Yang","year":"2020","journal-title":"Schizophr Bull"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1158\/1078-0432.CCR-18-1084","article-title":"Machine learning to build and validate a model for radiation pneumonitis prediction in patients with non-small cell lung cancer.","volume":"25","author":"Yu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/ije\/dyt110","article-title":"Power and sample size calculations for Mendelian randomization studies using one genetic instrument.","volume":"42","author":"Freeman","year":"2013","journal-title":"Int J Epidemiol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in Mendelian randomization studies.","volume":"42","author":"Brion","year":"2013","journal-title":"Int J Epidemiol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.3406","article-title":"An atlas of genetic correlations across human diseases and traits.","volume":"47","author":"Bulik-Sullivan","year":"2015","journal-title":"Nat Genet"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data.","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jtho.2021.02.024","article-title":"Tobacco smoking and risk of second primary lung cancer.","volume":"16","author":"Aredo","year":"2021","journal-title":"J Thorac Oncol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/ajcn\/82.3.657","article-title":"Alcohol consumption and risk of lung cancer: a pooled analysis of cohort studies.","volume":"82","author":"Freudenheim","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/cam4.4546","article-title":"BMI changes and the risk of lung cancer in male never-smokers: A prospective cohort study.","volume":"11","author":"Wu","year":"2022","journal-title":"Cancer Med"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00004872-200204000-00017","article-title":"Does hypertension increase mortality risk from lung cancer? A prospective cohort study on smoking, hypertension and lung cancer risk among Korean men.","volume":"20","author":"Lee","year":"2002","journal-title":"J Hypertens"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.ejca.2013.02.025","article-title":"Diabetes mellitus as an independent risk factor for lung cancer: a meta-analysis of observational studies.","volume":"49","author":"Lee","year":"2013","journal-title":"Eur J Cancer"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.nu.12.070192.002135","article-title":"Serum cholesterol and cancer risk: an epidemiologic perspective.","volume":"12","author":"Kritchevsky","year":"1992","journal-title":"Annu Rev Nutr"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/ije\/dyy262","article-title":"An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings.","volume":"48","author":"Sanderson","year":"2019","journal-title":"Int J Epidemiol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ajhg.2023.02.014","article-title":"Robust multivariable Mendelian randomization based on constrained maximum likelihood.","volume":"110","author":"Lin","year":"2023","journal-title":"Am J Hum Genet"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights.","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"113708","DOI":"10.1016\/j.jpba.2020.113708","article-title":"Metabonomics study on orthotopic transplantion mice model of colon cancer treated with Astragalus membranaceus-Curcuma wenyujin in different proportions via UPLC-Q-TOF\/MS.","volume":"193","author":"Sun","year":"2021","journal-title":"J Pharm Biomed Anal"},{"key":"R52-20250504","first-page":"183624","article-title":"Biomarker identification and pathway analysis by serum metabolomics of lung cancer.","volume":"2015","author":"Chen","year":"2015","journal-title":"Biomed Res Int"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"pkab059","DOI":"10.1093\/jncics\/pkab059","article-title":"Branched-chain amino acids and risk of breast cancer.","volume":"5","author":"Zeleznik","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/nbm.1345","article-title":"Metabolite profiling of fecal water extracts from human colorectal cancer.","volume":"22","author":"Monle\u00f3n","year":"2009","journal-title":"NMR Biomed"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40170-016-0151-y","article-title":"Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool.","volume":"4","author":"Brown","year":"2016","journal-title":"Cancer Metab"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12944-015-0070-x","article-title":"Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases.","volume":"14","author":"Raynor","year":"2015","journal-title":"Lipids Health Dis"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11046-021-00550-4","article-title":"Reassessing the use of undecanoic acid as a therapeutic strategy for treating fungal infections.","volume":"186","author":"Rossi","year":"2021","journal-title":"Mycopathologia"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.plefa.2008.09.005","article-title":"Linoleic acid and coronary heart disease.","volume":"79","author":"Harris","year":"2008","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1017\/S136898001500289X","article-title":"Linoleic acid and breast cancer risk: a meta-analysis.","volume":"19","author":"Zhou","year":"2016","journal-title":"Public Health Nutr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:17:40Z","timestamp":1746328660000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037085","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]}}}